Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32

被引:13
|
作者
Takagi, Kohji [1 ]
Imura, Johji [1 ]
Shimomura, Akiko [1 ]
Noguchi, Akira [1 ]
Minamisaka, Takashi [1 ]
Tanaka, Shinichi [1 ]
Nishida, Takeshi [1 ]
Hatta, Hideki [1 ]
Nakajima, Takahiko [1 ]
机构
[1] Univ Toyama, Acad Assembly, Fac Med, Dept Diagnost Pathol, 2630 Sugitani, Toyama, Toyama 9300194, Japan
基金
日本学术振兴会;
关键词
pancreatic cancer cell; invasion; comprehensive genomic analysis; cell culture; interleukin-32; INTERLEUKIN-32; PROGRESSION; GENE;
D O I
10.3892/ol.2020.11825
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Compared to tumors of other organs, pancreatic cancer is highly aggressive; with one of its biological features being that, despite a prominent fibrotic stroma, there is remarkable infiltration of tumor cells. This characteristic is considered to be the main reason for the poor prognosis of patients with pancreatic cancer. Therefore, in order to elucidate the factors that contribute to this high invasiveness, a selective invasion method was used to establish four highly invasive subclones from six human pancreatic cancer cell lines. The results demonstrated that two cell lines did not exhibit enhanced invasiveness. Microarray analysis revealed that, in the highly invasive cell lines, several genes were expressed at high levels, compared with the original cell lines. These highly expressed genes were recognized only in highly invasive cells. Among them,IL-32was most strongly upregulated in the highly invasive cells, compared with cells with a low invasive potential, as well as the original cells. RT-qPCR and western blot analysis confirmed the high levels of expression of IL-32 in highly invasive cells at the RNA and protein levels. In addition, immunohistochemical analysis of resected surgical materials revealed that the tumor cells expressed IL-32 and, in particular, many IL-32 positive cells were seen at the invasive front of the tumor tissue. IL-32 is a cytokine that is widely involved in the development of cancer and has recently received considerable attention. This cytokine has multiple splice variants and shows a wide variety of behaviors, depending on the tumor type and primary organ. Although some hypotheses have been proposed to explain the activity of IL-32, a unified view has not been agreed. In the present study, through the establishment of highly invasive cells from pancreatic cancer and a comprehensive gene analysis, it is suggested that IL-32 may serve an important role as a molecule involved in the invasiveness of this neoplasm.
引用
收藏
页码:2888 / 2896
页数:9
相关论文
共 50 条
  • [1] IL-32 regulate tumor cell invasion of pancreatic cancer.
    Imura, Johji
    Takagi, Kohji
    Shimomura, Akiko
    Kokaji, Eri
    Minamisaka, Takashi
    Miwa, Shigeharu
    Nakajima, Takahiko
    CANCER SCIENCE, 2018, 109 : 624 - 624
  • [2] Butyrate stimulates IL-32α expression in human intestinal epithelial cell lines
    Ayako Kobori
    Shigeki Bamba
    Hirotsugu Imaeda
    Hiromitsu Ban
    Tomoyuki Tsujikawa
    Yasuharu Saito
    Yoshihide Fujiyama
    Akira Andoh
    World Journal of Gastroenterology, 2010, 16 (19) : 2355 - 2361
  • [3] Butyrate stimulates IL-32α expression in human intestinal epithelial cell lines
    Kobori, Ayako
    Bamba, Shigeki
    Imaeda, Hirotsugu
    Ban, Hiromitsu
    Tsujikawa, Tomoyuki
    Saito, Yasuharu
    Fujiyama, Yoshihide
    Andoh, Akira
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (19) : 2355 - 2361
  • [4] Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines
    Heinhuis, Bas
    Plantinga, Theo S.
    Semango, George
    Kusters, Benno
    Netea, Mihai G.
    Dinarello, Charles A.
    Smit, Jan W. A.
    Netea-Maier, Romana T.
    Joosten, Leo A. B.
    CARCINOGENESIS, 2016, 37 (02) : 197 - 205
  • [5] IL-32 regulates downstream molecules to acquire invasiveness in pancreatic cancer
    Imura, Johji
    Noguchi, Akira
    Takagi, Kohji
    Shimomura, Akiko
    CANCER SCIENCE, 2021, 112 : 680 - 680
  • [6] IL-32 expression is an independent prognostic marker for gastric cancer
    Ishigami, Sumiya
    Arigami, Takaaki
    Uchikado, Yasuto
    Setoyama, Tetsuro
    Kita, Yoshiaki
    Sasaki, Ken
    Okumura, Hiroshi
    Kurahara, Hiroshi
    Kijima, Yuko
    Harada, Aya
    Ueno, Shinichi
    Natsugoe, Shoji
    MEDICAL ONCOLOGY, 2013, 30 (02)
  • [7] IL-32 Expression in Chronic Rhinosinusitis
    Kato, A.
    Keswani, A.
    Chustz, R. T.
    Peters, A.
    Chandra, R.
    Carter, R.
    Suh, L.
    Norton, J.
    Harris, K. E.
    Conley, D.
    Grammer, L. C.
    Kim, S.
    Dinarello, C. A.
    Kern, R. C.
    Schleimer, R. P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB61 - AB61
  • [8] IL-32 expression is an independent prognostic marker for gastric cancer
    Sumiya Ishigami
    Takaaki Arigami
    Yasuto Uchikado
    Tetsuro Setoyama
    Yoshiaki Kita
    Ken Sasaki
    Hiroshi Okumura
    Hiroshi Kurahara
    Yuko Kijima
    Aya Harada
    Shinichi Ueno
    Shoji Natsugoe
    Medical Oncology, 2013, 30
  • [9] IL-32 promotes breast cancer cell growth and invasiveness
    Wang, Shouman
    Chen, Feiyu
    Tang, Lili
    ONCOLOGY LETTERS, 2015, 9 (01) : 305 - 307
  • [10] Insights into the role of IL-32 in cancer
    Sloot, Yvette J. E.
    Smit, Johannes W.
    Joosten, Leo A. B.
    Netea-Maier, Romana T.
    SEMINARS IN IMMUNOLOGY, 2018, 38 (0C) : 24 - 32